Shaowei Qiu[Author] - Search Results

Year	Number of Results
2012	1
2013	1
2014	1
2015	1
2016	1
2017	4
2018	3
2019	1
2020	3
2021	5
2022	4
2023	9
2024	2

1

Metabolic adaptation to tyrosine kinase inhibition in leukemia stem cells.

Qiu S, Sheth V, Yan C, Liu J, Chacko BK, Li H, Crossman DK, Fortmann SD, Aryal S, Rennhack A, Grant MB, Welner RS, Paterson AJ, Wende AR, Darley-Usmar VM, Lu R, Locasale JW, Bhatia R. Qiu S, et al. Blood. 2023 Aug 10;142(6):574-588. doi: 10.1182/blood.2022018196. Blood. 2023. PMID: 37192295

2

Universal Anti-CD7 CAR-T Cells Targeting T-ALL and Functional Analysis of CD7 Antigen on T/CAR-T Cells.

Xie L, Gu R, Yang X, Qiu S, Xu Y, Mou J, Wang Y, Xing H, Tang K, Tian Z, Rao Q, Wang M, Wang J. Xie L, et al. Among authors: qiu s. Hum Gene Ther. 2023 Dec;34(23-24):1257-1272. doi: 10.1089/hum.2023.029. Epub 2023 Nov 24. Hum Gene Ther. 2023. PMID: 37861302

3

Microenvironmental CXCL12 deletion enhances Flt3-ITD acute myeloid leukemia stem cell response to therapy by reducing p38 MAPK signaling.

Anderson NR, Sheth V, Li H, Harris MW, Qiu S, Crossman DK, Kumar H, Agarwal P, Nagasawa T, Paterson AJ, Welner RS, Bhatia R. Anderson NR, et al. Among authors: qiu s. Leukemia. 2023 Mar;37(3):560-570. doi: 10.1038/s41375-022-01798-5. Epub 2022 Dec 22. Leukemia. 2023. PMID: 36550214 Free PMC article.

4

Altered Peripheral Blood Gene Expression in Childhood Cancer Survivors With Anthracycline-Induced Cardiomyopathy - A COG-ALTE03N1 Report.

Singh P, Shah DA, Jouni M, Cejas RB, Crossman DK, Magdy T, Qiu S, Wang X, Zhou L, Sharafeldin N, Hageman L, McKenna DE, Armenian SH, Balis FM, Hawkins DS, Keller FG, Hudson MM, Neglia JP, Ritchey AK, Ginsberg JP, Landier W, Bhatia R, Burridge PW, Bhatia S. Singh P, et al. Among authors: qiu s. J Am Heart Assoc. 2023 Oct 3;12(19):e029954. doi: 10.1161/JAHA.123.029954. Epub 2023 Sep 26. J Am Heart Assoc. 2023. PMID: 37750583 Free PMC article.

5

Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)-T therapy has potential to reduce escape from single-target CAR-T with no more hematotoxicity.

Wang Z, Lu Y, Liu Y, Mou J, Liu X, Chen M, Wang Y, Xu Y, Rao Q, Xing H, Tang K, Tian Z, Wang B, Qi W, Wang M, Qiu S, Xiong D, Wang J. Wang Z, et al. Among authors: qiu s. Cancer Commun (Lond). 2023 Oct;43(10):1178-1182. doi: 10.1002/cac2.12474. Epub 2023 Jul 31. Cancer Commun (Lond). 2023. PMID: 37525513 Free PMC article. No abstract available.

6

2B4 inhibits the apoptosis of natural killer cells through phosphorylated extracellular signal-related kinase/B-cell lymphoma 2 signal pathway.

Mou J, Xie L, Xu Y, Zhou T, Liu Y, Huang Q, Tang K, Tian Z, Xing H, Qiu S, Rao Q, Wang M, Wang J. Mou J, et al. Among authors: qiu s. Cytotherapy. 2023 Oct;25(10):1080-1090. doi: 10.1016/j.jcyt.2023.07.002. Epub 2023 Jul 29. Cytotherapy. 2023. PMID: 37516949

7

Low c-Kit expression identifies primitive, therapy-resistant CML stem cells.

Shah M, Kumar H, Qiu S, Li H, Harris M, He J, Abraham A, Crossman DK, Paterson A, Welner RS, Bhatia R. Shah M, et al. Among authors: qiu s. JCI Insight. 2023 Jan 10;8(1):e157421. doi: 10.1172/jci.insight.157421. JCI Insight. 2023. PMID: 36413413 Free PMC article.

8

Construction of CD19 targeted dual- and enhanced dual-antibodies and their efficiency in the treatment of B cell malignancy.

Chen M, Liu X, Peng N, Zhang T, Mou J, He H, Wang Y, Xu Y, Xing H, Tang K, Tian Z, Rao Q, Gu R, Qiu S, Wang M, Wang J. Chen M, et al. Among authors: qiu s. Exp Hematol Oncol. 2023 Jul 24;12(1):64. doi: 10.1186/s40164-023-00423-0. Exp Hematol Oncol. 2023. PMID: 37488603 Free PMC article.

9

A novel subclonal rearrangement of the STRN3::PDGFRB gene in de novo acute myeloid leukemia with NPM1 mutation and its leukemogenic effects.

Wang Z, Liu T, Liu W, Gao X, Wan L, Qiu S, Song Y, Gu R, Tian Z, Wang M, Wang J, Mi Y, Wei S. Wang Z, et al. Among authors: qiu s. Cancer Gene Ther. 2023 Nov;30(11):1471-1484. doi: 10.1038/s41417-023-00651-w. Epub 2023 Aug 7. Cancer Gene Ther. 2023. PMID: 37550570

10

The prognostic factors in acute myeloid leukaemia with double-mutated CCAAT/enhancer-binding protein alpha (CEBPAdm).

Wei H, Zhou C, Liu B, Lin D, Li Y, Wei S, Gong B, Zhang G, Liu K, Gong X, Fang Q, Liu Y, Qiu S, Gu R, Song Z, Chen J, Yang M, Zhang J, Jin J, Wang Y, Mi Y, Wang J. Wei H, et al. Among authors: qiu s. Br J Haematol. 2022 May;197(4):442-451. doi: 10.1111/bjh.18113. Epub 2022 Mar 10. Br J Haematol. 2022. PMID: 35274287

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

35 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Results by year